VCYT
Veracyte Inc

1,253
Mkt Cap
$3.43B
Volume
454,344.00
52W High
$50.71
52W Low
$22.61
PE Ratio
114.12
VCYT Fundamentals
Price
$42.20
Prev Close
$43.33
Open
$43.39
50D MA
$39.65
Beta
1.64
Avg. Volume
1.23M
EPS (Annual)
$0.3088
P/B
2.72
Rev/Employee
$540,975.73
Loading...
Loading...
News
all
press releases
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
Intuitive Surgical broadens its da Vinci SP system with FDA clearance for three new surgeries, expanding its role in minimally invasive care.
Zacks·6h ago
News Placeholder
More News
News Placeholder
First Trust Advisors LP Raises Holdings in Veracyte, Inc. $VCYT
First Trust Advisors LP increased its position in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 2.7% during the 2nd quarter, according to the company in its most recent disclosure with the...
MarketBeat·12h ago
News Placeholder
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor
Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving FDA approval for a first-in-human trial.
Zacks·1d ago
News Placeholder
Here's Why You Should Add Cencora Stock to Your Portfolio Now
Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
Zacks·1d ago
News Placeholder
JPMorgan Chase & Co. Buys 243,111 Shares of Veracyte, Inc. $VCYT
JPMorgan Chase & Co. lifted its stake in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 259.0% during the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·1d ago
News Placeholder
Arrowstreet Capital Limited Partnership Sells 165,322 Shares of Veracyte, Inc. $VCYT
Arrowstreet Capital Limited Partnership decreased its holdings in shares of Veracyte, Inc. (NASDAQ:VCYT - Free Report) by 33.7% in the 2nd quarter, according to the company in its most recent 13F...
MarketBeat·2d ago
News Placeholder
Insider Selling: Veracyte (NASDAQ:VCYT) Director Sells 20,000 Shares of Stock
Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) Director Karin Eastham sold 20,000 shares of the company's stock in a transaction on Friday, December 5th. The shares were sold at an average price of...
MarketBeat·2d ago
News Placeholder
Insider Selling: Veracyte (NASDAQ:VCYT) Director Sells 20,000 Shares of Stock
Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) Director Karin Eastham sold 20,000 shares of the company's stock in a transaction on Friday, December 5th. The shares were sold at an average price of...
MarketBeat·2d ago
News Placeholder
Insider Selling: Veracyte (NASDAQ:VCYT) Director Sells 20,000 Shares of Stock
Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) Director Karin Eastham sold 20,000 shares of the company's stock in a transaction on Friday, December 5th. The shares were sold at an average price of...
MarketBeat·2d ago
News Placeholder
Insider Selling: Veracyte (NASDAQ:VCYT) Director Sells 20,000 Shares of Stock
Veracyte, Inc. (NASDAQ:VCYT - Get Free Report) Director Karin Eastham sold 20,000 shares of the business's stock in a transaction on Friday, December 5th. The stock was sold at an average price of...
MarketBeat·3d ago

Latest VCYT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.